Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Contract Research Organization (CRO) and CDMO for Pharmaceutical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pharmaceutical accounting for % of the Contract Research Organization (CRO) and CDMO for Pharmaceutical global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Development segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Contract Research Organization (CRO) and CDMO for Pharmaceutical include Recipharm, AMRI3, Patheon, Aenova, and Catalent, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Contract Research Organization (CRO) and CDMO for Pharmaceutical market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Contract Research Organization (CRO) and CDMO for Pharmaceutical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Contract Research Organization (CRO) and CDMO for Pharmaceutical, with revenue, gross margin and global market share of Contract Research Organization (CRO) and CDMO for Pharmaceutical from 2019 to 2022.
Chapter 3, the Contract Research Organization (CRO) and CDMO for Pharmaceutical competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Contract Research Organization (CRO) and CDMO for Pharmaceutical market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Contract Research Organization (CRO) and CDMO for Pharmaceutical research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pharmaceutical accounting for % of the Contract Research Organization (CRO) and CDMO for Pharmaceutical global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Development segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Contract Research Organization (CRO) and CDMO for Pharmaceutical include Recipharm, AMRI3, Patheon, Aenova, and Catalent, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Contract Research Organization (CRO) and CDMO for Pharmaceutical market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Development
- API production
- Formulation
- Pharmaceutical
- Biopharmaceutical
- Recipharm
- AMRI3
- Patheon
- Aenova
- Catalent
- Amatsigroup
- WuXi PharmaTech
- Strides Shasun
- Piramal
- Siegfried
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Contract Research Organization (CRO) and CDMO for Pharmaceutical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Contract Research Organization (CRO) and CDMO for Pharmaceutical, with revenue, gross margin and global market share of Contract Research Organization (CRO) and CDMO for Pharmaceutical from 2019 to 2022.
Chapter 3, the Contract Research Organization (CRO) and CDMO for Pharmaceutical competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Contract Research Organization (CRO) and CDMO for Pharmaceutical market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Contract Research Organization (CRO) and CDMO for Pharmaceutical research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Contract Research Organization (CRO) and CDMO for Pharmaceutical
1.2 Classification of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Type
1.2.1 Overview: Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Type in 2021
1.2.3 Development
1.2.4 API production
1.2.5 Formulation
1.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market by Application
1.3.1 Overview: Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pharmaceutical
1.3.3 Biopharmaceutical
1.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size & Forecast
1.5 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast by Region
1.5.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region, (2017-2022)
1.5.3 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2017-2028)
1.5.4 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2017-2028)
1.5.6 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Drivers
1.6.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Restraints
1.6.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Trends Analysis
2 COMPANY PROFILES
2.1 Recipharm
2.1.1 Recipharm Details
2.1.2 Recipharm Major Business
2.1.3 Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.1.4 Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Recipharm Recent Developments and Future Plans
2.2 AMRI3
2.2.1 AMRI3 Details
2.2.2 AMRI3 Major Business
2.2.3 AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.2.4 AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 AMRI3 Recent Developments and Future Plans
2.3 Patheon
2.3.1 Patheon Details
2.3.2 Patheon Major Business
2.3.3 Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.3.4 Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Patheon Recent Developments and Future Plans
2.4 Aenova
2.4.1 Aenova Details
2.4.2 Aenova Major Business
2.4.3 Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.4.4 Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Aenova Recent Developments and Future Plans
2.5 Catalent
2.5.1 Catalent Details
2.5.2 Catalent Major Business
2.5.3 Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.5.4 Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Catalent Recent Developments and Future Plans
2.6 Amatsigroup
2.6.1 Amatsigroup Details
2.6.2 Amatsigroup Major Business
2.6.3 Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.6.4 Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Amatsigroup Recent Developments and Future Plans
2.7 WuXi PharmaTech
2.7.1 WuXi PharmaTech Details
2.7.2 WuXi PharmaTech Major Business
2.7.3 WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.7.4 WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 WuXi PharmaTech Recent Developments and Future Plans
2.8 Strides Shasun
2.8.1 Strides Shasun Details
2.8.2 Strides Shasun Major Business
2.8.3 Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.8.4 Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Strides Shasun Recent Developments and Future Plans
2.9 Piramal
2.9.1 Piramal Details
2.9.2 Piramal Major Business
2.9.3 Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.9.4 Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Piramal Recent Developments and Future Plans
2.10 Siegfried
2.10.1 Siegfried Details
2.10.2 Siegfried Major Business
2.10.3 Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.10.4 Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Siegfried Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Market Share in 2021
3.2.2 Top 10 Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Head Office, Products and Services Provided
3.4 Contract Research Organization (CRO) and CDMO for Pharmaceutical Mergers & Acquisitions
3.5 Contract Research Organization (CRO) and CDMO for Pharmaceutical New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Market Share by Type (2017-2022)
4.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Application (2017-2022)
5.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2028)
6.2 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2028)
6.3 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
6.3.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2028)
6.3.2 United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
6.3.3 Canada Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
6.3.4 Mexico Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2028)
7.2 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2028)
7.3 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
7.3.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2028)
7.3.2 Germany Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
7.3.3 France Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
7.3.5 Russia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
7.3.6 Italy Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2028)
8.2 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2028)
8.3 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region
8.3.1 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Region (2017-2028)
8.3.2 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
8.3.3 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
8.3.4 South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
8.3.5 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
8.3.7 Australia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2028)
9.2 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2028)
9.3 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
9.3.1 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2028)
9.3.2 Brazil Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
9.3.3 Argentina Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2028)
10.2 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2028)
10.3 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
10.3.1 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2028)
10.3.2 Turkey Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
10.3.4 UAE Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Contract Research Organization (CRO) and CDMO for Pharmaceutical
1.2 Classification of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Type
1.2.1 Overview: Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Type in 2021
1.2.3 Development
1.2.4 API production
1.2.5 Formulation
1.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market by Application
1.3.1 Overview: Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pharmaceutical
1.3.3 Biopharmaceutical
1.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size & Forecast
1.5 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast by Region
1.5.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region, (2017-2022)
1.5.3 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2017-2028)
1.5.4 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2017-2028)
1.5.6 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Drivers
1.6.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Restraints
1.6.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Trends Analysis
2 COMPANY PROFILES
2.1 Recipharm
2.1.1 Recipharm Details
2.1.2 Recipharm Major Business
2.1.3 Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.1.4 Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Recipharm Recent Developments and Future Plans
2.2 AMRI3
2.2.1 AMRI3 Details
2.2.2 AMRI3 Major Business
2.2.3 AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.2.4 AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 AMRI3 Recent Developments and Future Plans
2.3 Patheon
2.3.1 Patheon Details
2.3.2 Patheon Major Business
2.3.3 Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.3.4 Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Patheon Recent Developments and Future Plans
2.4 Aenova
2.4.1 Aenova Details
2.4.2 Aenova Major Business
2.4.3 Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.4.4 Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Aenova Recent Developments and Future Plans
2.5 Catalent
2.5.1 Catalent Details
2.5.2 Catalent Major Business
2.5.3 Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.5.4 Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Catalent Recent Developments and Future Plans
2.6 Amatsigroup
2.6.1 Amatsigroup Details
2.6.2 Amatsigroup Major Business
2.6.3 Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.6.4 Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Amatsigroup Recent Developments and Future Plans
2.7 WuXi PharmaTech
2.7.1 WuXi PharmaTech Details
2.7.2 WuXi PharmaTech Major Business
2.7.3 WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.7.4 WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 WuXi PharmaTech Recent Developments and Future Plans
2.8 Strides Shasun
2.8.1 Strides Shasun Details
2.8.2 Strides Shasun Major Business
2.8.3 Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.8.4 Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Strides Shasun Recent Developments and Future Plans
2.9 Piramal
2.9.1 Piramal Details
2.9.2 Piramal Major Business
2.9.3 Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.9.4 Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Piramal Recent Developments and Future Plans
2.10 Siegfried
2.10.1 Siegfried Details
2.10.2 Siegfried Major Business
2.10.3 Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
2.10.4 Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Siegfried Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Market Share in 2021
3.2.2 Top 10 Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Head Office, Products and Services Provided
3.4 Contract Research Organization (CRO) and CDMO for Pharmaceutical Mergers & Acquisitions
3.5 Contract Research Organization (CRO) and CDMO for Pharmaceutical New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Market Share by Type (2017-2022)
4.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Application (2017-2022)
5.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2028)
6.2 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2028)
6.3 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
6.3.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2028)
6.3.2 United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
6.3.3 Canada Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
6.3.4 Mexico Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2028)
7.2 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2028)
7.3 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
7.3.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2028)
7.3.2 Germany Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
7.3.3 France Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
7.3.5 Russia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
7.3.6 Italy Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2028)
8.2 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2028)
8.3 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region
8.3.1 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Region (2017-2028)
8.3.2 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
8.3.3 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
8.3.4 South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
8.3.5 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
8.3.7 Australia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2028)
9.2 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2028)
9.3 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
9.3.1 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2028)
9.3.2 Brazil Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
9.3.3 Argentina Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2028)
10.2 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2028)
10.3 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
10.3.1 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2028)
10.3.2 Turkey Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
10.3.4 UAE Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) by Region (2017-2022)
Table 5. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region (2023-2028)
Table 6. Recipharm Corporate Information, Head Office, and Major Competitors
Table 7. Recipharm Major Business
Table 8. Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 9. Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. AMRI3 Corporate Information, Head Office, and Major Competitors
Table 11. AMRI3 Major Business
Table 12. AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 13. AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Patheon Corporate Information, Head Office, and Major Competitors
Table 15. Patheon Major Business
Table 16. Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 17. Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Aenova Corporate Information, Head Office, and Major Competitors
Table 19. Aenova Major Business
Table 20. Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 21. Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Catalent Corporate Information, Head Office, and Major Competitors
Table 23. Catalent Major Business
Table 24. Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 25. Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Amatsigroup Corporate Information, Head Office, and Major Competitors
Table 27. Amatsigroup Major Business
Table 28. Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 29. Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. WuXi PharmaTech Corporate Information, Head Office, and Major Competitors
Table 31. WuXi PharmaTech Major Business
Table 32. WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 33. WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Strides Shasun Corporate Information, Head Office, and Major Competitors
Table 35. Strides Shasun Major Business
Table 36. Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 37. Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Piramal Corporate Information, Head Office, and Major Competitors
Table 39. Piramal Major Business
Table 40. Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 41. Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Siegfried Corporate Information, Head Office, and Major Competitors
Table 43. Siegfried Major Business
Table 44. Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 45. Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Head Office, Products and Services Provided
Table 50. Contract Research Organization (CRO) and CDMO for Pharmaceutical Mergers & Acquisitions in the Past Five Years
Table 51. Contract Research Organization (CRO) and CDMO for Pharmaceutical New Entrants and Expansion Plans
Table 52. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) by Type (2017-2022)
Table 53. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Type (2017-2022)
Table 54. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Forecast by Type (2023-2028)
Table 55. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2022)
Table 56. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Forecast by Application (2023-2028)
Table 57. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) by Region (2017-2022)
Table 5. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region (2023-2028)
Table 6. Recipharm Corporate Information, Head Office, and Major Competitors
Table 7. Recipharm Major Business
Table 8. Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 9. Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. AMRI3 Corporate Information, Head Office, and Major Competitors
Table 11. AMRI3 Major Business
Table 12. AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 13. AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Patheon Corporate Information, Head Office, and Major Competitors
Table 15. Patheon Major Business
Table 16. Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 17. Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Aenova Corporate Information, Head Office, and Major Competitors
Table 19. Aenova Major Business
Table 20. Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 21. Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Catalent Corporate Information, Head Office, and Major Competitors
Table 23. Catalent Major Business
Table 24. Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 25. Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Amatsigroup Corporate Information, Head Office, and Major Competitors
Table 27. Amatsigroup Major Business
Table 28. Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 29. Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. WuXi PharmaTech Corporate Information, Head Office, and Major Competitors
Table 31. WuXi PharmaTech Major Business
Table 32. WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 33. WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Strides Shasun Corporate Information, Head Office, and Major Competitors
Table 35. Strides Shasun Major Business
Table 36. Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 37. Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Piramal Corporate Information, Head Office, and Major Competitors
Table 39. Piramal Major Business
Table 40. Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 41. Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Siegfried Corporate Information, Head Office, and Major Competitors
Table 43. Siegfried Major Business
Table 44. Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
Table 45. Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Head Office, Products and Services Provided
Table 50. Contract Research Organization (CRO) and CDMO for Pharmaceutical Mergers & Acquisitions in the Past Five Years
Table 51. Contract Research Organization (CRO) and CDMO for Pharmaceutical New Entrants and Expansion Plans
Table 52. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) by Type (2017-2022)
Table 53. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Type (2017-2022)
Table 54. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Forecast by Type (2023-2028)
Table 55. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2022)
Table 56. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Forecast by Application (2023-2028)
Table 57. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Contract Research Organization (CRO) and CDMO for Pharmaceutical Picture
Figure 2. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Type in 2021
Figure 3. Development
Figure 4. API production
Figure 5. Formulation
Figure 6. Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Application in 2021
Figure 7. Pharmaceutical Picture
Figure 8. Biopharmaceutical Picture
Figure 9. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region (2017-2028)
Figure 12. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region in 2021
Figure 13. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Drivers
Figure 19. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Restraints
Figure 20. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Trends
Figure 21. Recipharm Recent Developments and Future Plans
Figure 22. AMRI3 Recent Developments and Future Plans
Figure 23. Patheon Recent Developments and Future Plans
Figure 24. Aenova Recent Developments and Future Plans
Figure 25. Catalent Recent Developments and Future Plans
Figure 26. Amatsigroup Recent Developments and Future Plans
Figure 27. WuXi PharmaTech Recent Developments and Future Plans
Figure 28. Strides Shasun Recent Developments and Future Plans
Figure 29. Piramal Recent Developments and Future Plans
Figure 30. Siegfried Recent Developments and Future Plans
Figure 31. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Players in 2021
Figure 32. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 33. Global Top 3 Players Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share in 2021
Figure 34. Global Top 10 Players Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share in 2021
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 36. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Type in 2021
Figure 37. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share Forecast by Type (2023-2028)
Figure 38. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Application in 2021
Figure 39. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share Forecast by Application (2023-2028)
Figure 40. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 41. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 42. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Country (2017-2028)
Figure 43. United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 47. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 48. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Country (2017-2028)
Figure 49. Germany Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 55. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region (2017-2028)
Figure 57. China Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 64. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 65. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 69. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 70. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Country (2017-2028)
Figure 71. Turkey Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Saudi Arabia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. UAE Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Contract Research Organization (CRO) and CDMO for Pharmaceutical Picture
Figure 2. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Type in 2021
Figure 3. Development
Figure 4. API production
Figure 5. Formulation
Figure 6. Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Application in 2021
Figure 7. Pharmaceutical Picture
Figure 8. Biopharmaceutical Picture
Figure 9. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region (2017-2028)
Figure 12. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region in 2021
Figure 13. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Drivers
Figure 19. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Restraints
Figure 20. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Trends
Figure 21. Recipharm Recent Developments and Future Plans
Figure 22. AMRI3 Recent Developments and Future Plans
Figure 23. Patheon Recent Developments and Future Plans
Figure 24. Aenova Recent Developments and Future Plans
Figure 25. Catalent Recent Developments and Future Plans
Figure 26. Amatsigroup Recent Developments and Future Plans
Figure 27. WuXi PharmaTech Recent Developments and Future Plans
Figure 28. Strides Shasun Recent Developments and Future Plans
Figure 29. Piramal Recent Developments and Future Plans
Figure 30. Siegfried Recent Developments and Future Plans
Figure 31. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Players in 2021
Figure 32. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 33. Global Top 3 Players Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share in 2021
Figure 34. Global Top 10 Players Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share in 2021
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 36. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Type in 2021
Figure 37. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share Forecast by Type (2023-2028)
Figure 38. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Application in 2021
Figure 39. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share Forecast by Application (2023-2028)
Figure 40. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 41. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 42. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Country (2017-2028)
Figure 43. United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 47. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 48. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Country (2017-2028)
Figure 49. Germany Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 55. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region (2017-2028)
Figure 57. China Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 64. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 65. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 69. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 70. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Country (2017-2028)
Figure 71. Turkey Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Saudi Arabia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. UAE Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
